Showing results (3631-3640 of 5,227) with videos related to

Sort By:
Pageof 523
Antiviral Research|February 9, 2008
Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA virusesKevin B Spurgers, C Matthew Sharkey, Kelly L Warfield, et al.
Antiviral Research|November 16, 2018
PASylated interferon α efficiently suppresses hepatitis B virus and induces anti-HBs seroconversion in HBV-transgenic miceYuchen Xia, Martin Schlapschy, Volker Morath, et al.
Antiviral Research|October 20, 2018
Vitamin D derivatives inhibit hepatitis C virus production through the suppression of apolipoproteinAsako Murayama, Hiroshi Saitoh, Akiko Takeuchi, et al.
Antiviral Research|October 22, 2018
Protease inhibitors broadly effective against feline, ferret and mink coronavirusesKrishani Dinali Perera, Anushka C Galasiti Kankanamalage, Athri D Rathnayake, et al.
Antiviral Research|November 6, 2018
Antiviral activity of metal chelates of caffeic acid and similar compounds towards herpes simplex, VSV-Ebola pseudotyped and vaccinia virusesJeffrey Langland, Bertram Jacobs, Carl E Wagner, et al.
Antiviral Research|November 6, 2018
Street rabies virus strains associated with insectivorous bats are less pathogenic than strains isolated from other reservoirsNatalia Langenfeld Fuoco, Elaine Raniero Fernandes, Sandriana Dos Ramos Silva, et al.
Antiviral Research|November 5, 2018
In vitro evaluation of novel reverse transcriptase inhibitors TAF (tenofovir alafenamide) and OBP-601 (2,3-didehydro-3-deoxy-4-ethynylthymidine) against multi-drug resistant primary isolates of HIV-2Inês Bártolo, Pedro Borrego, Perpétua Gomes, et al.
Antiviral Research|November 4, 2018
The optimized fusion protein HA1-2-FliCΔD2D3 promotes mixed Th1/Th2 immune responses to influenza H7N9 with low induction of systemic proinflammatory cytokines in miceLi Song, Dan Xiong, Xilong Kang, et al.
Antiviral Research|November 6, 2018
Novel amodiaquine derivatives potently inhibit Ebola virus infectionYasuteru Sakurai, Norikazu Sakakibara, Masaaki Toyama, et al.
Antiviral Research|November 20, 2018
In vivo proof-of-concept for two experimental antiviral drugs, both directed to cellular targets, using a murine cytomegalovirus modelEric Sonntag, Friedrich Hahn, Luca D Bertzbach, et al.
Pageof 523